Jaguar Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;'>JH</div>
JAGX -- USA Stock  

USD 2.78  0.48  14.72%

As many rational traders are trying to avoid healthcare space, it makes sense to break down Jaguar Health a little further and understand how it stands against Equillium and other similar entities. We are going to inspect some of the competitive aspects of both Jaguar and Equillium.
Published over two weeks ago
View all stories for Jaguar Health | View All Stories
Is Jaguar (NASDAQ:JAGX) catching up with Equillium (NASDAQ:EQ)?
By analyzing existing basic indicators between Jaguar Health and Equillium, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Equillium with a short position in Jaguar Health. Check out our pair correlation module for more information.

Let's begin by analyzing the assets. The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Jaguar Health has an asset utilization ratio of 67.07 percent. This suggests that the company is making $0.67 for each dollar of assets. An increasing asset utilization means that Jaguar Health is more efficient with each dollar of assets it utilizes for everyday operations.
Out of tens of thousands of stocks, funds, and ETFs that trade on global exchanges each represent an individual company which you can analyze using comparative analysis. To determine which one of the two companies, such as Jaguar or Precision is a better fit for your portfolio, analyzing a few basic fundamental indicators is a good first step.

How important is Jaguar Health's Liquidity

Jaguar Health financial leverage refers to using borrowed capital as a funding source to finance Jaguar Health ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Jaguar Health financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Jaguar Health's total debt and its cash.

Correlation Between Jaguar and Precision BioSciences

In general, stock analysis is a method for investors and traders to make individual buying and selling decisions. Stock correlation analysis is also essential because it can help investors realize that they may not be as diversified as they think. Risk management strategies are usually required to make sure all portfolios are properly aligned against their risk tolerance level. You can consider holding Jaguar Health together with similar or unrelated positions with a negative correlation. For example, you can also add Precision BioSciences to your portfolio. If Precision BioSciences is not perfectly correlated to Jaguar Health it will diversify some of the market risks out of the positively correlated stocks in your portfolio. However, the disadvantage of this sort of hedging is that it can potentially affect your investment returns throughout market cycles. When Jaguar Health for example, for example, performs excellent and delivers stable returns, the negatively correlated position you locked in as a hedge may drag your returns down. Please check pair correlation details between JAGX and DTIL for more information.

Note

Are you currently holding both Jaguar Health and Precision BioSciences in your portfolio? Please note if you are using this as a pair-trade strategy between Jaguar Health and Precision BioSciences, watch out for correlation discrepancy over time. Relying on the historical price correlations and assuming that it will not change may lead to short-term losses.

Acquisition by James Bochnowski of 45486 shares of Jaguar Health subject to Rule 16b-3

Legal trades by Jaguar Health insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Jaguar Health insider trading alert for grant of stock option (right to buy) by James Bochnowski, the corporate stakeholder, on 25th of March 2020. This event was filed by Jaguar Health Inc with SEC on 2020-03-25. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking down Jaguar Health Indicators

Cash and Equivalents Breakdown

Now, let's check Jaguar Health cash and equivalents. In accordance with the recently published financial statements, Jaguar Health has 1.35 M in Cash and Equivalents. This is 99.84% lower than that of the Healthcare sector and 99.7% lower than that of the Biotechnology industry. The cash and equivalents for all United States stocks is 99.95% higher than that of the company. As for Equillium we see cash and equivalents of 90.54 M, which is 79.75% lower than that of the Biotechnology

Sector
447.1 M
JAGX1.35 Million0.25
Sector447.12 Million82.95
EQ90.54 Million16.8

Another 3 percent rise for Jaguar Health

The value at risk is down to -11.54 as of today. As of the 9th of January, Jaguar Health retains the Downside Deviation of 9.84, market risk adjusted performance of (2.41), and Risk Adjusted Performance of 0.2191. Jaguar Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Jaguar Health, which can be compared to its competitors. Please check out Jaguar Health information ratio, as well as the relationship between the potential upside and kurtosis to decide if Jaguar Health is priced fairly, providing market reflects its last-minute price of 4.0 per share. Given that Jaguar Health has jensen alpha of 5.95, we strongly advise you to confirm Jaguar Health's regular market performance to make sure the company can sustain itself at a future point.

Our Bottom Line On Jaguar Health

While some other entities within the biotechnology industry are still a little expensive, even after the recent corrections, Jaguar Health may offer a potential longer-term growth to investors. With a somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither take in new shares of Jaguar nor exit your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Jaguar Health.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Jaguar Health. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com